Latest filing published 26 Oct 2023 for Titan Pharmaceuticals INC. Read the official filing
No signal scores available.
Eric Howard Greenberg is a declared insider of Titan Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 26 July 2023 to 25 October 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 26 October 2023: a share grant, in Titan Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations